US Stock MarketDetailed Quotes

JAZZ Jazz Pharmaceuticals

Watchlist
  • 108.990
  • -1.500-1.36%
Close May 17 16:00 ET
  • 108.270
  • -0.720-0.66%
Post 17:35 ET
6.87BMarket Cap22.57P/E (TTM)

About Jazz Pharmaceuticals Company

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.

Company Profile

SymbolJAZZ
Company NameJazz Pharmaceuticals
Listing DateJun 1, 2007
Issue Price18.00
Founded2005
CEOMr. Bruce C. Cozadd
MarketNASDAQ
Employees2800
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
AddressWaterloo Exchange,Waterloo Road,5th Floor
CityDublin
ProvinceDublin
CountryIreland
Zip Code4
Phone353-1-634-7800

Company Executives

  • Name
  • Position
  • Salary
  • Bruce C. Cozadd
  • Chairman of the Board and Chief Executive Officer
  • 17.33M
  • Neena M. Patil
  • Executive Vice President and Chief Legal Officer
  • --
  • Patricia Carr
  • Senior Vice President and Chief Accounting Officer
  • --
  • Renee D. Gala
  • President and Chief Operating Officer
  • 5.03M
  • Philip L. Johnson
  • Executive Vice President and Chief Financial Officer
  • --
  • Dr. Finbar Larkin, PhD
  • Senior Vice President, Technical Operations
  • --
  • Dr. Robert Iannone, M.D.
  • Executive Vice President and Global Head of Research and Development
  • 4.86M
  • Samantha Pearce
  • Senior Vice President, Europe and International
  • --
  • Patrick G. Enright
  • Independent Director
  • 481.18K
  • Rick E. Winningham
  • Lead Independent Director
  • 522.11K
  • Heather Ann McSharry
  • Independent Director
  • 499.46K
  • Patrick Thomas Kennedy
  • Independent Director
  • --
  • Jennifer E. Cook
  • Independent Director
  • 481.32K
  • Kenneth W. O'Keefe
  • Independent Director
  • 468.68K
  • Peter P. Gray
  • Independent Director
  • 489.46K
  • Dr. Norbert G. Riedel,PhD
  • Independent Director
  • 488.59K
  • Anne O'Riordan
  • Independent Director
  • 475.42K
  • Dr. Catherine Angell Sohn, Pharm.D.
  • Independent Director
  • 477.84K
  • Dr. Mark D. Smith, M.D.
  • Independent Director
  • 472.11K
  • Seamus C. Mulligan
  • Independent Director
  • 482.86K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg